Subscribe to Entrepreneur for $5
Subscribe

The Zacks Analyst Blog Highlights: NVR, Toll Brothers, Meritage Homes, KB Home and Tri Pointe Homes

The Zacks Analyst Blog Highlights: NVR, Toll Brothers, Meritage Homes, KB Home and Tri Pointe Homes

By
This story originally appeared on Zacks

For Immediate Release

Chicago, IL – September 20, 2021 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: NVR, Inc. NVR, Toll Brothers, Inc. TOL, Meritage Homes Corporation MTH, KB Home KBH and Tri Pointe Homes, Inc. TPH.

- Zacks

Here are highlights from Friday’s Analyst Blog:

Mortgage Rates Stay Below 3%: Top 5 Housing Stocks to Buy

The U.S. housing industry is likely to retain its positive momentum on low mortgage rates, which remained below 3% for the majority of 2021. Per Freddie Mac's latest Primary Mortgage Market Survey, the average U.S. 30-year fixed-rate mortgage for the week ended Sep 16 declined 2 basis points (bps) to 2.86% from a week ago. The metric also declined 1 bps from 2.87% recorded in the corresponding prior-year period.

The 15-year fixed-rate mortgage for the week averaged 2.12%, down 7 bps from the prior week, while the five-year adjustable-rate mortgage rose 9 bps to 2.51%.

Since the onset of the pandemic, housing demand is on the rise as people have been looking for new and larger homes to work from home in lower-density markets, including small metro areas, rural markets, and large metro exurbs.

Yet, persistent supply chain disruptions since the pandemic, record-high lumber prices, and significant job loss ailed the homebuilding and related construction industries. The impact is clearly visible from the industry's collective price performance in the past year. The Zacks Building Products - Home Builders industry has gained just 11.8% compared with the Zacks Construction sector and S&P 500 composite's 33.5% and 38.9% rally, respectively, in the said period.

Will the Industry Rebound in 2H21?

Home sales are rising at a record pace, defying low inventory levels and Delta variant coronavirus cases. The desire for more space and amenities to accommodate working and learning from home along with the Fed's dovish stance should continue to boost the U.S. housing market in the near term.

The recent housing data reveals encouraging market prospects. For the week ended Sep 10, Mortgage applications increased 0.3% from the week earlier, per the latest Mortgage Bankers Association's Weekly Mortgage Applications Survey. Purchase applications rose more than 7% to the highest level since April 2021. The results include an adjustment for the Labor Day holiday.

Input prices used for residential construction, excluding energy, fell 0.7% in August from a month ago, per the latest Producer Price Index report released by the Bureau of Labor Statistics. The downturn was largely due to a decline in lumber and wood products prices. This was the first monthly decline since the start of the last recession.

On a further encouraging note, hiring in the construction sector increased 5.2% in July from the June reading, per the recent BLS' Job Openings and Labor Turnover report. Private residential construction spending also rose 0.5% in July from the June reading, per the Census Bureau in its recent Monthly Construction Spending report. Total private residential construction spending was 27% higher than a year ago.

These uptrends in housing statistics are pointing to significant strength in the industry's fundamentals.

Stocks to Bet on

Backed by solid housing metrics and forgoing woes, we have listed five top-ranked stocks from the Zacks Building Products - Home Builders industry that investors may add to their portfolio. These stocks have been picked with the help of the Zacks Stock Screener and carry a Zacks Rank #1 (Strong Buy) or 2 (Buy). You can see the complete list of today's Zacks #1 Rank stocks here.

NVR: This Zacks Rank #2 homebuilder banks on a disciplined business model, and focuses on maximizing liquidity as well as minimizing risks. Its shares have gained 21.2% in the past year. Earnings estimates for the current year have witnessed an upward revision of 8.7% in the past 60 days, indicating 51.3% year-over-year growth.

Toll Brothers: This luxury homebuilding company also currently carries a Zacks Rank #2. Toll Brothers primarily rides on limited competition in the market, and the strategy of broadening product lines, price points as well as geographies. Its shares have gained 41.4% in the past year. Earnings estimates for the current year have witnessed an upward revision of 9.1% in the past 30 days, suggesting 80% year-over-year growth.

Meritage Homes Corp.: This leading designer and builder of single-family homes mainly benefits from strategic initiatives to boost profitability and focus on entry-level LiVE.NOW homes. Earnings estimates for the year have moved 28.9% upward in the past 60 days, implying 72.4% year-over-year growth. The company's shares have appreciated 3.6% over a year. Although the stock has underperformed the industry, the positive estimate revision is encouraging. Currently, it sports a Zacks Rank #1.

KB Home: This single-family homebuilder has been pursuing a Returns-Focused Growth Plan that is designed to drive revenues and homebuilding operating income margin. This Zacks Rank #2 company's shares have gained 10.7% in the past year, almost in line with the industry. Earnings estimates for the year have increased 4% in the past 60 days, pointing to 99% year-over-year growth.

Tri Pointe Homes: This company is involved in the design, construction, and sale of single-family detached and attached homes. Primarily, it has been gaining from robust demand, pricing and better operating leverage. Its shares have gained 28.9% over a year. In the past two months, the company's earnings estimates have moved up 14.2%, indicating 66.8% year-over-year growth.

Media Contact

Zacks Investment Research

800-767-3771 ext. 9339

support@zacks.com

https://www.zacks.com

Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.



Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $2.4 trillion by 2028 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Recommendations from previous editions of this report have produced gains of +205%, +258% and +477%. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>



Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

 

Toll Brothers Inc. (TOL): Free Stock Analysis Report

 

KB Home (KBH): Free Stock Analysis Report

 

Meritage Homes Corporation (MTH): Free Stock Analysis Report

 

NVR, Inc. (NVR): Free Stock Analysis Report

 

Tri Pointe Homes Inc. (TPH): Free Stock Analysis Report

 

To read this article on Zacks.com click here.

 

Zacks Investment Research